IP Verse

Compositions And Methods Of Identifying Tumor Specific Neoantigens

Patent No. EP2569633 (titled "Compositions And Methods Of Identifying Tumor Specific Neoantigens") was filed by Dana Farber Cancer Institute on May 16, 2011. The application was issued on Feb 10, 2016.

Patent Summary

Patent Family

Patent family tree
Statuses, jurisdictions and citation links are shared on request.

Patent Oppositions (5)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
STRAWMANNov 10, 2016MEWBURN ELLIS
AGENUSNov 9, 2016CARPMAELS & RANSFORD
JAMES POOLENov 9, 2016HOFFMANN EITLE
MÃœLLER, CHRISTIANNov 9, 2016SCHNAPPAUF
GRITSTONE ONCOLOGYNov 7, 2016VOSSIUS & PARTNER PATENTANWALTE RECHTSANWALTE MBB

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

EP2569633

DANA FARBER CANCER INSTITUTE
Application Number
EP11781409A
Filing Date
May 16, 2011
Status
Revoked
Sep 9, 2022
Publication Date
Feb 10, 2016
External Links
Slate, Register , Google Patents